MENLO PARK, Calif.,
Mar. 16, 2017 /PRNewswire/
-- BioPharmX Corporation (NYSE MKT: BPMX), a specialty
pharmaceutical company developing products for the dermatology
market, today announced that it will release its financial results
for the fiscal fourth quarter ended Jan. 31,
2017 after the close of trading on Thursday, Mar. 23, 2017. The company's
management team will host a corresponding conference call beginning
at 1:30 p.m. PT/4:30 p.m. ET to discuss the financial results
along with full year and recent business developments.
Individuals interested in listening to the conference call may
do so by dialing (866) 652-5200 for domestic callers or (412)
317-6060 for international callers, and request to join the
BioPharmX Corporation call. To listen to a live webcast,
please visit the investor relations section of the BioPharmX
website at: www.BioPharmX.com.
A replay of the call will be available beginning Mar. 23 at 3:30 p.m.
PT/6:30 p.m. ET through
midnight ET on Apr. 24, 2017. To access the replay, dial
(877) 344-7529 or (412) 317-0088 and reference Conference ID:
10103314. The webcast will also be available on the BioPharmX
website for 90 days following the completion of the call.
About BioPharmX® Corporation
BioPharmX Corporation
(NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical
company, that seeks to provide products through proprietary
platform technologies for prescription, over-the-counter (OTC), and
supplement applications in the health and wellness markets,
including dermatology and women's health. To learn more about
BioPharmX, visit www.BioPharmX.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-to-report-fourth-quarter-and-full-year-financial-results-300424354.html
SOURCE BioPharmX Corporation